Human ZNHIT6 (C1orf181) knockout HeLa cell line
Be the first to review this product! Submit a review
|
(0 Publication)
Human ZNHIT6 (C1orf181) knockout HeLa cell line available to order. Recommended control: Human wild-type HeLa cell line (ab255928).
View Alternative Names
BCD1_HUMAN, Box C/D snoRNA essential 1 homolog, Box C/D snoRNA protein 1, Chromosome 1 open reading frame 181, FLJ20729, FLJ20760, HIT type zinc finger containing protein C1orf181, Hypothetical protein LOC54680, MGC131963, NY BR 75, Serologically defined breast cancer antigen NY-BR-75, ZNHIT6, Zinc finger HIT domain-containing protein 6, Zinc finger, HIT type 6, Zinc finger, HIT type containing 6
- Sanger seq
Unknown
Sanger Sequencing - Human ZNHIT6 (C1orf181) knockout HeLa cell line (AB265532)
Allele-2 : 2 bp insertion in exon 1.
- Sanger seq
Unknown
Sanger Sequencing - Human ZNHIT6 (C1orf181) knockout HeLa cell line (AB265532)
Allele-1 : 1 bp insertion in exon 1.
Product details
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Handling procedures
Initial handling guidelines
Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.
1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.
Subculture guidelines
- All seeding densities should be based on cell counts gained by established methods.
- A guide seeding density of 2x104 cells/cm2 is recommended.
- Cells should be passaged when they have achieved 80-90% confluence.
Culture medium
DMEM (High Glucose) + 10% FBS
Cryopreservation medium
Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
C1orf181 is associated with cellular processes that impact gene regulation and protein interactions. Although not much is known about its role evidence suggests it might be involved in protein complexes that contribute to maintaining cellular homeostasis. The structure or partners in these complexes have not been fully identified but ongoing research is aiming to unveil its interacting partners and biological implications.
Pathways
The involvement of C1orf181 may connect to regulatory networks influencing cell growth and signaling. Studies indicate potential association with the MAPK signaling pathway an important mechanism in cell proliferation and differentiation. Additionally interactions with proteins like ERK1/2 which are vital components of this pathway point towards C1orf181 influencing downstream cellular responses.
Quality control
STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com